Cancer sites for which there is“sufficient” evidence of carcinogenicity of tobacco smoking according to the International Agency for Research on Cancer Working Group
Cancer site | Studies | RR | |
Case–control | Cohort | ||
Lung | >100 | 37 | 15–30 |
Urinary tract | 50 | 24 | 3 |
Upper aero-digestive tract | |||
Oral cavity | |||
Oro-and hypopharynx | 28 | 6 | 4–5 |
Oesophagus | 45 | 19 | 1.5–5 |
Larynx | 25 | 5 | 10 |
Pancreas | 38 | 27 | 2–4 |
Nasal cavity, paranasal sinuses | 9 | 1 | 1.5–2.5 |
Nasopharynx | 9 | 2 | 1.5–2.5 |
Stomach | 44 | 27 | 1.5–2 |
Liver | 29 | 29 | 1.5–2.5 |
Kidney | 13 | 8 | 1.5–2.0 |
Uterine cervix | 49 | 14 | 1.5–2.5 |
Myeloid leukaemia | NR | 12 | 1.5–2 |